Skip to main content
. 2017 Aug 2;14(4):3198–3206. doi: 10.3892/etm.2017.4876

Figure 1.

Figure 1.

Plasma levels of (A) ECP (***P<0.001 vs. AECOPD and AECOPD/PE at ECP), (B) EDN (***P<0.001 vs. AECOPD and AECOPD/PE at EDN), (C) EPX (*P<0.05 vs. AECOPD/PE at EPX; **P<0.01 vs. AECOPD at EPX) and (D) MBP in normal controls (n=35), patients with AECOPD/PE (n=30) and patients with AECOPD (n=47) (***P<0.001 vs. AECOPD and AECOPD/PE at MBP). The edges of the boxes represent the interquartile ranges, and the solid lines drawn across the boxes represent the medians. ECP, eosinophil cationic protein; EDN, eosinophil-derived neurotoxin; EPX, eosinophil peroxidase; MBP, major basic protein; AECOPD, acute exacerbation of chronic obstructive pulmonary disease; PE, pulmonary embolism.